Cardinal Health, Inc. (NYSE:CAH) to Issue $0.52 Quarterly Dividend

Cardinal Health, Inc. (NYSE:CAH) announced a quarterly dividend on Monday, August 10th. Stockholders of record on Thursday, October 1st will be paid a dividend of 0.5158 per share on Thursday, October 15th. This represents a c) dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Thursday, October 1st.

Cardinal Health has raised its dividend by an average of 0.0%per year over the last three years and has increased its dividend every year for the last 29 years. Cardinal Health has a dividend payout ratio of 22.7% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Cardinal Health to earn $12.04 per share next year, which means the company should continue to be able to cover its $2.06 annual dividend with an expected future payout ratio of 17.1%.

Cardinal Health Trading Up 1.2%

CAH stock opened at $240.08 on Wednesday. The firm has a 50 day moving average of $228.37 and a 200-day moving average of $216.66. The firm has a market capitalization of $56.23 billion, a P/E ratio of 36.71, a price-to-earnings-growth ratio of 1.16 and a beta of 0.49. Cardinal Health has a 12 month low of $137.75 and a 12 month high of $258.30.

Cardinal Health (NYSE:CAH) last posted its earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. During the same quarter in the prior year, the firm posted $2.08 EPS. Cardinal Health’s revenue was up 5.8% on a year-over-year basis. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Sell-side analysts predict that Cardinal Health will post 10.77 EPS for the current year.

Cardinal Health News Summary

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Profit and guidance beat expectations. Cardinal Health reported fiscal Q4 non-GAAP EPS of $2.91, up from $2.08 a year earlier and $0.49 above consensus. Fiscal 2027 adjusted EPS guidance of $12.40–$12.60 also exceeded the approximately $12.05 analyst estimate, implying 13%–15% growth. Cardinal Health forecasts full-year profit above estimates on specialty drug strength
• Positive Sentiment: Specialty-drug and medtech performance supported earnings. Sustained demand for specialty pharmaceuticals helped drive the outlook, while medical technology profits nearly doubled in the quarter. Cardinal also said it now exclusively serves nearly half of the cell-and-gene therapy market, strengthening its position in a higher-margin growth niche. Cardinal Health nearly doubles medtech profits, fueling Q4 earnings beat
• Positive Sentiment: Large buyback authorization added support. The board approved an additional $5 billion for share repurchases after Cardinal bought back $1.4 billion of stock during fiscal 2026. The company also declared a quarterly dividend of $0.5158 per share, payable October 15. Cardinal Health Reports Fourth Quarter and Fiscal Year 2026 Results
• Neutral Sentiment: Revenue growth was solid but missed forecasts. Fourth-quarter revenue rose 6% year over year to $63.67 billion, but fell short of the roughly $65.15 billion consensus estimate. Fiscal 2026 operating cash flow reached $5.2 billion and adjusted free cash flow was $5.0 billion. Cardinal Health shares rise as profit beats estimates and outlook tops forecasts
• Negative Sentiment: Some earnings quality and valuation concerns remain. About $0.31 of quarterly adjusted EPS came from a one-time IEEPA tariff refund, while the Global Medical Products and Distribution segment reported declining revenue. With CAH trading near its 52-week high and at an elevated valuation, investors may demand continued execution to justify further gains. Can Cardinal Health’s Strong Earnings Guidance Offset a Mixed Quarter?

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.